Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer
Anne‐Vibeke Lænkholm, Maj‐Britt Jensen, Jens Ole Eriksen, Anne Roslind, Wesley Buckingham, Sean Ferree, Torsten O. Nielsen, Bent Ejlertsen
Topics & Concepts
MedicineOncologyBreast cancerInternal medicineEstrogen receptorPostmenopausal womenPopulationCancerEnvironmental healthBreast Cancer Treatment StudiesBreast Lesions and CarcinomasHER2/EGFR in Cancer Research